Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yinuo
Contact Yinuo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Risankizumab: Mechanism of action, clinical and translational science
Mechanism of action: Binds to the p19 subunit of interleukin-23 (IL-23) and inhibits IL-23 from interacting with the IL-23 receptor and subsequent signaling. Indications: Plaque psoriasis (PsO), psoriatic arthritis (PsA), Crohn's disease (CD). Japan only indications: Generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP), and palmoplantar pustulosis (PPP).
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/art.42415.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Yinuo
Contact Yinuo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack